Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Dark Star Minerals Inc. Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.	Canada	BATT
DBV Technologies Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.	France	DBV
DD GROUP Co.,Ltd. Operates a diverse portfolio of food service, amusement, and hotel brands.	Japan	3073
Decollte Holdings Corporation A nationwide network of studios offering modern wedding photography and wellness services.	Japan	7372
Dedem SpA Diversified group providing photo booths, amusement rides, 3D printing, and tech solutions.	Italy	DDM
Dedicare European recruitment and staffing firm for healthcare, life science, and social work sectors.	Sweden	DEDI
Delta-Fly Pharma, Inc. Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.	Japan	4598
DENISON MINES CORP. Uranium exploration and development company advancing projects in Canada's Athabasca Basin.	United States of America	DNN
DENTSU GROUP INC. Global advertising & marketing firm integrating tech and consulting for brand growth.	Japan	4324
DGA S.A. Consulting, training, and EU-funded project services for public and private organizations.	Poland	DGA